Results 41 to 50 of about 13,477 (288)
ARC syndrome accompanied with glaucoma in one of two affected siblings. [PDF]
Pediatrics International, Volume 67, Issue 1, January/December 2025.
Okuno T+4 more
europepmc +2 more sources
Purpose: Many intraocular pressure (IOP)-lowering medications contain benzalkonium chloride (BAK), a preservative associated with unfavorable outcomes.
A. Halder, A. Khopade
semanticscholar +1 more source
Introduction New open-angle glaucoma (OAG) and ocular hypertension (OHT) therapies that reduce treatment burden and improve outcomes relative to currently available agents are needed.
S. Asrani+7 more
semanticscholar +1 more source
Peripheral Latanoprost Administration Lowers Intraocular Pressure in the Wistar Rat
Purpose Instillation of latanoprost eye drops into the conjunctival sac to lower intraocular pressure (IOP) is the most frequently used treatment for primary open-angle glaucoma.
Maciej Świątkiewicz+5 more
doaj +1 more source
Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or ...
Jeanette A. Stewart+6 more
doaj +1 more source
Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]
There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm+36 more
core +2 more sources
A Study of Iridectomy Histopathologic Features of Latanoprost- andNon–Latanoprost-Treated Patients [PDF]
To examine the histopathologic features of iridectomy specimens from patients undergoing glaucoma surgery and to compare histologic abnormalities in a group of patients with a history of latanoprost therapy with those in a group of patients who had no history of prostaglandin therapy (controls).Iridectomy specimens and patient history forms were ...
Christine M. Damico+7 more
openaire +2 more sources
Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]
A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case series of 20 patients with uveitis and secondary raised ...
Gurbaxani, A+3 more
core +1 more source
Ocular manifestations of Sturge–Weber syndrome: pathogenesis, diagnosis, and management [PDF]
Sturge-Weber syndrome has been included in the group of phakomatoses that is characterized by hamartomas involving the brain, skin, and eyes. The characteristic facial port-wine stain, involving the first branch of the trigeminal nerve and the embryonic ...
Abdolrahimzadeh, Solmaz+4 more
core +1 more source
ObjectiveAs monotherapy is insufficient for some patients, the existing fixed-dose combination (FDC) requires two or more daily administrations with declining adherence.
Nachuan Luo+9 more
doaj +1 more source